NASDAQ:TTOO

T2 Biosystems Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

$0.143

+0.0129 (+9.92%)

At Close: Jun 20, 2025

T2 Biosystems Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -5.68. In total, the insiders bought 1 192 371 448 and sold 4 326 430 674 TTOO shares in the last 100 trades.

Insider Power (Last 100 transactions)	-5.68
Buy	11 923 714 Shares
Sell	43 264 307 Shares

Historical Insider Trades

Date	Type	Action	Person	Amount
Nov 04, 2024	Restricted Stock Units	Buy	Liebman Seymour	25 000
Nov 04, 2024	Restricted Stock Units	Buy	Giffin Brett A.	180 000
Nov 04, 2024	Restricted Stock Units	Buy	Adams Laura Lee	25 000
Nov 04, 2024	Restricted Stock Units	Buy	Cumming John W	35 000
Nov 04, 2024	Restricted Stock Units	Buy	Gibbs Michael Terrence	190 000
Nov 04, 2024	Restricted Stock Units	Buy	Saunders Ninfa	25 000
Nov 04, 2024	Restricted Stock Units	Buy	Toft Robin	25 000
Nov 04, 2024	Restricted Stock Units	Buy	Sperzel John J Iii	490 000
Nov 04, 2024	Restricted Stock Units	Buy	Elsbree David B	25 000
Nov 04, 2024	Restricted Stock Units	Buy	Sprague John M	180 000
Sep 13, 2024	Common Stock	Sell	Elsbree David B	55
May 09, 2024	Common Stock	Buy	Cr Group L.p.	108 752
May 09, 2024	Common Stock	Buy	Cr Group L.p.	1 716 048
May 09, 2024	Series A Preferred Stock	Sell	Cr Group L.p.	17 160
May 09, 2024	Series B Preferred Stock	Sell	Cr Group L.p.	10 875
May 03, 2024	Common Stock	Buy	Cr Group L.p.	1 565 445
May 03, 2024	Common Stock	Buy	Cr Group L.p.	2 001 514
May 03, 2024	Common Stock	Buy	Cr Group L.p.	648 139
May 03, 2024	Common Stock	Buy	Cr Group L.p.	403 608
May 03, 2024	Common Stock	Buy	Cr Group L.p.	129 629
Apr 12, 2024	Common Stock	Buy	Cr Group L.p.	1 647 315
Apr 12, 2024	Common Stock	Buy	Cr Group L.p.	390 142
Apr 12, 2024	Common Stock	Buy	Cr Group L.p.	682 036
Apr 12, 2024	Common Stock	Buy	Cr Group L.p.	424 716
Apr 12, 2024	Common Stock	Buy	Cr Group L.p.	136 409

ABOUT T2 BIOSYSTEMS

T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine. The company also offers T2Dx Instrument, a bench-top instrument that runs various diagn...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
G GTM $9.57	2.40%	Jun 02
TAC $8.90	23.37%	May 12
IMMR $7.28	4.81%	May 09
UAA $5.84	20.38%	May 09
MEDP $300.81	2.84%	May 08

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by